Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasneurology-neurodisability-and-neuromuscular

Paeds Vivas · neurology-neurodisability-and-neuromuscular

Antiseizure medicines: selection, adverse effects and monitoring — branching viva

Branching viva on antiseizure medicine selection, adverse effects and monitoring: classifying the drug by spectrum and mechanism, choosing the syndrome-matched first-choice medicine, recognising the adverse-effect signature of each agent, applying the valproate pregnancy prevention programme, and managing the lamotrigine rash and the carbamazepine hyponatraemia scenarios.

branching clinical structured oral1 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
Outpatient clinic: a ten-year-old boy with newly diagnosed focal epilepsy, started on levetiracetam two weeks ago, whose parents report new irritability and aggression, and whose seizures are now controlled. The examiner asks: classify the drug by spectrum and mechanism, explain the behavioural adverse effect and its management — then branches to the spectrum rule (why carbamazepine would also work for focal but worsens absence), the valproate pregnancy prevention programme applied to a female adolescent, and the lamotrigine rash scenario that tests the slow-titration rule.

Opening question

A ten-year-old boy with focal epilepsy is two weeks into levetiracetam and his parents report new irritability and aggression. His seizures are controlled. Classify the drug by spectrum and mechanism, explain the behavioural adverse effect and its approximate frequency, and outline your management. [5] [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 2013.PMID 23350722
  2. [5]Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol, 2012.PMID 22832500
  3. [7]Pack AM, Oskoui M, Williams Roberson S, et al. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology, 2024.PMID 38748979
  4. [11]Guberman AH, Besag FM, Brodie MJ, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia, 1999.PMID 10403224
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute neuromuscular respiratory failure: Vivaneurology-neurodisability-and-neuromuscularNextAtaxia in children: Vivaneurology-neurodisability-and-neuromuscular